因降低风险或治疗指征行双侧输卵管卵巢切除术的患者中同期子宫手术及激素治疗的使用情况
这项10年回顾性研究分析了643例因降低风险或治疗指征行双侧输卵管卵巢切除术(BSO)患者的临床资料,采用多项回归分析评估与同期子宫手术相关的因素,并描述手术方式及术后激素治疗(HT)使用趋势。结果显示,黑人种族、激素受体阳性乳腺癌病史及手术医生与同期子宫切除术显著相关,符合条件的51岁以下患者中36%启动HT,研究期间子宫切除术率下降而子宫内膜取样增加。
要点
- 黑人种族、激素受体阳性乳腺癌病史及手术医生与同期子宫切除术显著相关。
- 符合条件的51岁以下患者中36%启动术后激素治疗。
- 研究期间同期子宫切除术率下降,子宫内膜取样增加。
核心结论
- 研究期间子宫切除术率下降,略超过三分之一的符合条件的患者使用了术后激素治疗。
- 需要进一步研究同期子宫手术,以在降低风险和治疗性BSO人群中建立标准化治疗推荐。
- 有必要对符合条件的患者进行关于术后激素治疗益处的教育。
研究设计与样本
- 一项为期10年的回顾性研究,纳入在一家机构接受降低风险或治疗性双侧输卵管卵巢切除术(BSO)的患者,共643例。
- 对患者和病例特征进行多项回归分析,评估与手术类型(BSO、BSO加子宫切除术或BSO加子宫内膜取样)的相关性,并描述手术类型及术后激素治疗使用趋势。
主要发现
- 643例患者中,140例(22%)因激素受体(HR)阳性乳腺癌病史接受治疗性BSO,其余因致病性变异和/或家族史接受降低风险BSO。
- 致病性变异包括BRCA1(141例,40%)、BRCA2(173例,49%)和林奇综合征基因(15例,4%)。
- 回归分析显示,同期子宫切除术与黑人种族(RR=3.55,CI=1.51-8.38,p=0.004)、HR阳性乳腺癌病史(RR=1.88,CI=1.03-3.42,p=0.04)及手术医生(医生1,RR=2.43,CI=1.36-4.35,p=0.003)显著相关。
- 符合条件的51岁以下患者中,36%启动术后激素治疗。
- 研究期间,同期子宫切除术率下降,而子宫内膜取样增加。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This study aimed to analyze factors associated with concurrent uterine surgery in patients undergoing bilateral salpingo-oophorectomy (BSO) for risk reducing or therapeutic purposes. Additionally, trends in surgical choice and uptake of post-operative hormone therapy (HT) were examined. METHODS: A 10-year retrospective study was conducted on patients who underwent risk-reducing or therapeutic BSO at one institution. Multinomial regression analysis of patient and case characteristics was performed evaluating associations with surgery type (BSO, BSO and hysterectomy, or BSO and endometrial sampling). Trends in surgery type and uptake of HT post operatively are described. RESULTS: Among the study sample of 643 patients, 140 (22%) patients underwent therapeutic BSO for a history of hormone receptor (HR) positive breast cancer, while the remainder underwent risk-reducing BSO due to a pathogenic variant and/or family history. Pathogenic variants included BRCA1 (141, 40%) BRCA2 (173, 49%), and Lynch syndrome genes (15, 4%). Regression analysis revealed significant associations between concurrent hysterectomy and Black race (RR = 3.55, CI = 1.51-8.38, p = 0.004), history of HR positive breast cancer (RR = 1.88, CI = 1.03-3.42, p = 0.04), and surgeon (Surgeon 1, RR = 2.43, CI = 1.36-4.35, p = 0.003). Among eligible patients under age 51, 36% initiated HT. Over the study period, concurrent hysterectomy rates declined while endometrial sampling increased. CONCLUSIONS: Rates of hysterectomy declined over the study period and slightly more than one-third of eligible patients utilized post-operative HT. Further research on concurrent uterine surgery is needed to establish standardized treatment recommendations in the risk-reducing and therapeutic BSO population. Additionally, education regarding the benefits of postoperative HT in eligible patients is warranted.
引用
- Sasse SA, Lee SS, Rajeev P, et al. Concurrent uterine surgery and uptake of hormone therapy in patients undergoing bilateral salpingo-oophorectomy for risk-reducing or therapeutic indications. Gynecol Oncol. 2023. PMID: 37988946. doi:10.1016/j.ygyno.2023.10.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。